Consulting

Whether you are a sole proprietorship interested in developing an innovative ophthalmic product concept, or a large biopharma company looking at acquisition targets, the Ora Consulting Team can help you attain your goals in the most cost-efficient and time-efficient manner possible.

Due Diligence
Ora regularly performs due diligence for investors and companies that are considering M&A activity within the ophthalmic space.
Preclinical Consulting
Ora has extensive experience in preclinical consulting across multiple disciplines.
Clinical Consulting
Ora has decades of experience in clinical consulting across all ophthalmic sub-specialties, from allergy and dry eye to glaucoma and retinal diseases.
Regulatory Consulting
For over 40 years, Ora has scheduled regular interfaces with the FDA, enabling us to prepare informed clinical-regulatory strategies for our clients.

Whether you are a sole proprietorship interested in developing an innovative ophthalmic product concept, or a large biopharma company looking at acquisition targets, the Ora Consulting Team can help you attain your goals in the most cost-efficient and time-efficient manner possible.

With three decades of experience within the ophthalmic space, Ora is able to offer truly unique consulting value across all ophthalmic therapeutic areas. We can guide you through the entire development process, from product and indication identification through development, licensing and marketing. Or, if you only need consulting on a specific development stage, we are also able to provide a limited consulting engagement at any individual development stage along the way.

The Ora Consulting Team can help you structure the most efficient development plan for your ophthalmic drug or device candidate. We are uniquely qualified to provide a comprehensive plan by tying together strategies across:

We consult a broad array of clients, including:

We consult with these clients on many different levels, including:

Due Diligence

Ora regularly performs due diligence for investors and companies that are considering M&A activity within the ophthalmic space. We specialize in:

Preclinical Consulting

Ora has extensive experience in preclinical consulting across the following disciplines:

Clinical Consulting

Ora has decades of experience in clinical consulting across all ophthalmic sub-specialties, from allergy and dry eye to glaucoma and retinal diseases. Our key services include:

  • Development of the proper study design for the product’s unique Mechanism of Action
  • Optimal selection of endpoints
  • Optimal selection of dosing schedule
  • Sequencing of studies
  • Sub-group identification
  • Obtaining the most efficient POC
  • Building value inflection by creating data sets that will resonate with all key stakeholders